AI Summary
This case series investigates the impact of immune checkpoint inhibitor-based therapies compared to best supportive care on the overall survival of patients with unresectable hepatocellular carcinoma and Child-Pugh class B liver dysfunction.
This case series examines the association of immune checkpoint inhibitor–based therapies vs best supportive care with the overall survival of patients with unresectable hepatocellular carcinoma and Child-Pugh class B liver dysfunction.